TY  - GEN
AU  - Colombel,J-F
AU  - Jharap,B
AU  - Sandborn,W J
AU  - Feagan,B
AU  - Peyrin-Biroulet,L
AU  - Eichner,S F
AU  - Robinson,A M
AU  - Mostafa,N M
AU  - Zhou,Q
AU  - Thakkar,R B
TI  - Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy
SN  - 1365-2036
PY  - 2017///0829
KW  - Adalimumab
KW  - administration & dosage
KW  - Adult
KW  - Anti-Inflammatory Agents
KW  - Colitis, Ulcerative
KW  - blood
KW  - Crohn Disease
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Immunologic Factors
KW  - Male
KW  - Middle Aged
KW  - Remission Induction
KW  - methods
KW  - Treatment Failure
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1111/apt.13838
ER  -